Welcome to GeneProof website!

It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.

GeneProof Team


User account
Forgot your password?

IVDR – Regulation (EU) 2017/746

IVDR – Regulation (EU) 2017/746
GeneProof has smoothly transitioned to the new IVDR legislation as planned and expected.

As of 27 May 2022, the company's activities are fully compliant with Regulation (EU) 2017/746 of the European Parliament and of the Council, as amended.

We successfully fulfilled requirements of IVD Regulation 2017/746 and all related requirements for production and selling of in vitro diagnostics in European Union after 26th May, 2022.

We could continue to offer and sell the whole portfolio of more than 80 CE IVD products under the new EU IVD rules.

All Class A products (according to Annex VIII, IVDR) have been newly issued with the appropriate EU Declaration of Conformity in accordance with the IVDR and have been newly notified to the national authority, the SÚKL.

  • myCROBE® Fully Automated Instrument
  • croBEE® NA16 Nucleic Acid Extraction System Plus
  • croBEE® Real-Time PCR System
  • croBEE® 2.0 Nucleic Acid Extraction System
  • croBEE® 201A Nucleic Acid Extraction Kit
  • GeneProof PathogenFree DNA Isolation Kit
  • GeneProof PathogenFree RNA Isolation Kit
  • myCROBE® / croBEE® 2.0 Universal Extraction Kit
  • myCROBE® / croBEE® 2.0 Blood Pretreatment Sample tube

All products that were previously in Lists A and B according to the IVDD (HBV, HCVD, HIV-1, HIV1D, CMV, CMV MC, CT, CT MC, CNMX and CP) are fully certified and benefit from a transition period until 01/2024

All other PCR kits (which were classified as other IVD devices according to the IVDD) are fully compliant with the REGULATION (EU) 2022/112 – (IVDR amendment of 01/2022) and are fully available.


Nevertheless, we successfully continue on our way to IVDR certification of „B“, „C“ and „D“ Class devices:

  • GeneProof has successfully completed both QMS (IVDR) certification audits conducted by NB2797 (BSI) in 08/2021.
  • A total of 25 class kits (D, C and B) are in the advanced stage of technical documentation review.
  • The first GeneProof group of IVDR certified products will be available in Q3 2022
  • GeneProof SARS-CoV-2 IVDR PCR Kit has successfully undergone the expert panel review as the first kit detecting SARS-CoV-2 in EU
  • GeneProof HIV type 1 (HIV-1) Diagnostic PCR Kit was accepted for assessment of Notified Body (BSI)

We are very proud that we do not reduce the number of CE IVD kits in the future and are completing all necessary documentation and testing for the technical files of the rest of our product portfolio.

You can count on GeneProof – today and in the future!

IVDR FAQ – What does it mean for laboratories?

How will the new IVDR rules affect my laboratory?

Not if you use GeneProof products.

How is GeneProof prepared for IVDR?

The GeneProof Quality Management System and GeenProof products are fully compliant with IVDR as amended.

GeneProof's class „A“ products (Nucleic Acid Extractions and all Instruments) are CE certified to IVDR requirements  and the company is successfully progressing  towards the planned  IVDR certification of all its  class „B“, „C“ and „D“ products as planned.

Can I use RUO products in my lab?

No. The use of IVD products that are not properly CE certified (in accordance with the IVDR as amended) is strictly banned in clinical laboratories in the European Union.

What are the current rules for extraction kits for PCR diagnostics?

CExtraction kits are classified as Class A under the IVDR Regulation and as such must be CE marked (IVDR) from the date of application of the Regulation (i.e. 27 May 2022). This means that all IVD extraction kits (and instruments, accessories etc.) manufactured after 26 May 2022 must have a new EU Declaration of Conformity meeting the requirements of the new IVDR legislation.

Laboratories using IVD products that do not meet this requirement are acting in breach of EU Regulation 2017/746 as amended (i.e. IVDR) and may be subject to sanctions under the relevant national legislation.

All GeneProof Class A products have a proper new Declaration of Conformity and meet all IVDR requirements for this class of in vitro diagnostic medical devices.

Why is CE IVD product certification so important?

CE IVD certification means that the product complies with the relevant applicable EU legislation, has the declared characteristics and the manufacturer takes full responsibility for it.

In terms of patient safety, the use of unregulated RUO (Research-Use-Only) products in clinical laboratories is prohibited in the European Union for any diagnostic in human medicine.

Can I still use tests developed by my lab (in-house methods, LDT)?

So far yes, but the new IVD Regulation is very strict on this issue, although the deadlines have been extended. Currently, IVDR requirements do not only apply to devices manufactured and used within a single legal entity.

Within two years, laboratories using in-house methods must ensure that certain specified conditions have been met.

What conditions will a laboratory using in-house methods have to meet under IVDR?

The laboratory could only use in-house tests if there are no commercially available CE IVD products in the EU.

The laboratory must then have/comply with:

  • General Safety and Performance Requirements (Annex I, IVDR)
  • Quality management system covering the manufacture of the IVD devices used
  • ISO 15189 certification (Medical laboratories - Specific quality and competence requirements)
  • Justification for the use of in-house IVD
  • CAPA system
  • Overview of experience gained from clinical use of the device
  • Post-market surveillance system in place
Do you want to ask more? Do not hesitate to contact us on [obfuscate_1_|108|88|112|106|92|115|96|108|102|55|102|92|108|100|103|113|102|109|101|37|98|102|107].